Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Randomized, Single Dose Study, to Assess Dose Proportionality and Pharmacokinetic Linearity of Saninova Tablets Manufactured by Sichuan Credit Pharmaceutical Co., Ltd, China In Healthy Participants Under Fasting Conditions.

NCT07664657 is registered in ClinicalTrials.gov with Sichuan Credit Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07664657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07664657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Randomized, Single Dose Study, to Assess Dose Proportionality and Pharmacokinetic Linearity of Saninova Tablets Manufactured by Sichuan Credit Pharmaceutical Co., Ltd, China In Healthy Participants Under Fasting Conditions.
Lead sponsor
Sichuan Credit Pharmaceutical Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
July 31, 2026
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioavailability and pharmacokinetics